Skibinski A, Kuperwasser C
Department of Developmental, Chemical, and Molecular Biology, Tufts University, Boston, MA 02111, USA.
Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Oncogene. 2015 Oct 16;34(42):5309-16. doi: 10.1038/onc.2014.475. Epub 2015 Feb 23.
How breast diversity is generated is a fascinating and fundamental question with important clinical implications. It is clear that the diversity of phenotypes displayed by breast cancer cells reflects the array of cell types present in the disease-free breast epithelium, including luminal, basal and stem cells. Therefore, it is hypothesized that the molecular regulators governing normal development of the breast epithelium may double as engines of breast tumor diversity. In the past few years, a deepened understanding of the mammary epithelial hierarchy has prompted the search for the cellular precursors of breast tumors. At the same time, the use of novel experimental strategies including the new technology of massively parallel sequencing has provided insight into the origin and evolution of breast tumors. Here, we review the current understanding of the basis of the intrinsic subtypes and the sources of inter-tumor heterogeneity.
乳腺多样性是如何产生的,这是一个引人入胜的基本问题,具有重要的临床意义。很明显,乳腺癌细胞所表现出的表型多样性反映了无病乳腺上皮中存在的一系列细胞类型,包括管腔细胞、基底细胞和干细胞。因此,有人推测,调控乳腺上皮正常发育的分子调节因子可能兼作乳腺肿瘤多样性的驱动因素。在过去几年中,对乳腺上皮层次结构的深入理解促使人们寻找乳腺肿瘤的细胞前体。与此同时,包括大规模平行测序新技术在内的新型实验策略的应用,为乳腺肿瘤的起源和演变提供了见解。在此,我们综述了目前对内在亚型基础以及肿瘤间异质性来源的理解。